Clinical trial Recruiting at 1 site Observational Ages 18 and up

On-site Simulation Training to Improve Infection Prevention in an Adult ICU

Official title: Impact of an On-site Simulation-based Training Programme on Adherence to Standard Precautions and Healthcare-associated Infections in Adult Intensive Care : Prospective Quasi-experimental Before-and-after Study

Run by Centre Hospitalier Régional Metz-Thionville · NCT07822971 · Data updated 2026-11-12

A 18‑month, single‑center effort tests whether repeated in‑situ simulation training helps ICU staff consistently follow standard precautions and reduce infections.

More Upper Cross Syndrome trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1000 (estimated)
SponsorCentre Hospitalier Régional Metz-Thionville
Academic / other
Locations1 site (Metz)
StatusRecruiting
StartedMarch 1, 2026
Main results expectedAugust 31, 2027
Study endsMarch 2028
Registry record updatedSeptember 24, 2026
Trial IDNCT07822971 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) admitted to the participating ICU with stays of 48 hours or more and with usable outcome data in the records.

Probably not a fit

Patients whose infections are driven by factors beyond standard precautions or whose care is not influenced by staff training may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, before‑and‑after study takes place in one adult ICU over 18 months, with 6 months before training, 6 months of hands‑on simulation sessions, and 6 months after. The intervention uses SIMREA, an in situ simulation program aiming to strengthen knowledge, technical skills, and teamwork needed to reliably apply standard precautions. The study compares infection-related outcomes before and after the simulation training while accounting for real‑world ICU challenges. Outcomes are based on data from electronic health records and routine surveillance. Eligible participants are adults (18+) admitted to the ICU with stays of at least 48 hours and for whom outcome data are available.

Why it matters

Potential benefit: If successful, the program could improve adherence to infection prevention practices and reduce hospital‑acquired infections in ICUs.

How similar studies have gone: Past studies using in situ simulation to strengthen infection control have shown improvements in adherence and some reductions in infections in ICU settings.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients hospitalized in the adult intensive care unit at CHR Metz-Thionville during the study period
* Patients aged 18 years or older
* Patients with a length of stay in the intensive care unit of 48 hours or more
* Patients for whom the data necessary to assess the outcome measures are available in the electronic health record and/or hospital surveillance databases
* Patients who have been informed about the use of their health data for research purposes, in accordance with the procedures established by the institution

Exclusion Criteria:

* Patients who, after being informed, objected to the use of their health data for this research

Where it's running

  • CHR Metz-Thionville, Hôpital de Mercy
    Metz, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.